| 1 |
33085988 | Identification of 7,8-dihydroxy-3-phenylcoumarin as a reversible monoamine oxidase enzyme inhibitor. | 2021 Feb |
1 |
| 2 |
34102520 | Synthesis of new hydrazone derivatives and evaluation of their monoamine oxidase inhibitory activity. | 2021 Sep |
1 |
| 3 |
32337091 | Biocatalytic Synthesis of Moclobemide Using the Amide Bond Synthetase McbA Coupled with an ATP Recycling System. | 2020 Apr 17 |
1 |
| 4 |
32601846 | Monoamine oxidase A inhibition as monotherapy reverses parkinsonism in the MPTP-lesioned marmoset. | 2020 Nov |
1 |
| 5 |
32621059 | Monoamine oxidase A inhibition with moclobemide enhances the anti-parkinsonian effect of L-DOPA in the MPTP-lesioned marmoset. | 2020 Nov |
2 |
| 6 |
29320717 | Imitation of phase I metabolism reactions of MAO-A inhibitors by titanium dioxide photocatalysis. | 2018 Mar 1 |
2 |
| 7 |
30242487 | Epigenetic signature of MAOA and MAOB genes in mental disorders. | 2018 Nov |
1 |
| 8 |
25466703 | The separate and combined effects of monoamine oxidase inhibition and nicotine on P50 sensory gating. | 2015 Jun |
1 |
| 9 |
26316187 | Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors. | 2015 Aug 27 |
5 |
| 10 |
24115740 | 5-(2-Aminopropyl)indole (5-IT): a psychoactive substance used for recreational purposes is an inhibitor of human monoamine oxidase (MAO). | 2014 Jul-Aug |
1 |
| 11 |
23361656 | Evaluation of selective human MAO inhibitory activities of some novel pyrazoline derivatives. | 2013 Jun |
1 |
| 12 |
23437843 | Discovery, biological evaluation, and structure-activity and -selectivity relationships of 6'-substituted (E)-2-(benzofuran-3(2H)-ylidene)-N-methylacetamides, a novel class of potent and selective monoamine oxidase inhibitors. | 2013 Mar 28 |
1 |
| 13 |
21570786 | Serotonin toxicity involving MDMA (ecstasy) and moclobemide. | 2012 Feb 10 |
1 |
| 14 |
22396688 | Comparison of treatment adherence between selective serotonin reuptake inhibitors and moclobemide in patients with social anxiety disorder. | 2012 Mar |
1 |
| 15 |
23153282 | Synthesis of new 7-oxycoumarin derivatives as potent and selective monoamine oxidase A inhibitors. | 2012 Dec 13 |
1 |
| 16 |
21463543 | Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [11C]-harmine PET study. | 2011 Nov |
3 |
| 17 |
19687003 | Serotonin toxicity caused by moclobemide too soon after paroxetine-selegiline. | 2009 Aug |
1 |
| 18 |
16079787 | Positron emission tomography quantification of [11C]-harmine binding to monoamine oxidase-A in the human brain. | 2006 Mar |
2 |
| 19 |
16702990 | Moclobemide upregulated Bcl-2 expression and induced neural stem cell differentiation into serotoninergic neuron via extracellular-regulated kinase pathway. | 2006 Jul |
2 |
| 20 |
15804499 | Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide. | 2005 Apr 11 |
1 |
| 21 |
15907150 | Social anxiety disorder : current treatment recommendations. | 2005 |
1 |
| 22 |
20711287 | Comparison of the efficacy and safety of moclobemide and imipramine in the treatment of depression in Indian patients. | 2005 Apr |
1 |
| 23 |
15048616 | The effects of moclobemide on autonomic and cognitive functions in healthy volunteers. | 2004 Mar |
1 |
| 24 |
12606609 | Mapping the cerebral monoamine oxidase type A: positron emission tomography characterization of the reversible selective inhibitor [11C]befloxatone. | 2003 May |
1 |
| 25 |
12765230 | Fatal combination of moclobemide overdose and whisky. | 2003 Mar |
3 |
| 26 |
12833310 | Pharmacological treatment of frontotemporal dementia: treatment response to the MAO-A inhibitor moclobemide. | 2003 Jul |
1 |
| 27 |
22033639 | Treatment of seasonal affective disorders. | 2003 Dec |
1 |
| 28 |
11801236 | Pharmacotherapy of social anxiety disorder. | 2002 Jan 1 |
1 |
| 29 |
11999916 | Treatment of comorbid opiate addiction and attention-deficit hyperactivity disorder (residual type) with moclobemide: a case report. | 2002 Apr |
2 |
| 30 |
12131599 | Moclobemide is effective and well tolerated in the long-term pharmacotherapy of social anxiety disorder with or without comorbid anxiety disorder. | 2002 Jul |
1 |
| 31 |
12163988 | Moclobemide response in depressed patients: association study with a functional polymorphism in the monoamine oxidase A promoter. | 2002 Jul |
1 |
| 32 |
12190330 | Clinical pharmacokinetics of intranasal sumatriptan. | 2002 |
1 |
| 33 |
12665046 | Moclobemide in the treatment of hot flashes in postmenopausal women. | 2002 Nov-Dec |
1 |
| 34 |
11195257 | Efficacy and tolerability of moclobemide in bulimia nervosa: a placebo-controlled trial. | 2001 Jan |
1 |
| 35 |
11309556 | Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19. | 2001 Apr |
1 |
| 36 |
11422001 | Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans. | 2001 May |
1 |
| 37 |
11460889 | Clinically significant drug interactions with agents specific for migraine attacks. | 2001 |
1 |
| 38 |
11465638 | Effects of moclobemide on sexual performance and nocturnal erections in psychogenic erectile dysfunction. | 2001 Jun |
1 |
| 39 |
10760560 | The in vitro immunosuppressive effects of moclobemide in healthy volunteers. | 2000 Apr |
1 |
| 40 |
11030484 | A randomized, double-blind placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome. | 2000 Sep |
1 |
| 41 |
11249525 | Migraine pharmacotherapy with oral triptans: a rational approach to clinical management. | 2000 Mar |
1 |
| 42 |
9987207 | Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression. | 1999 Jan |
1 |
| 43 |
10063483 | Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression. | 1999 Mar |
1 |
| 44 |
10333164 | Undesirable blood pressure changes under naturalistic treatment with moclobemide, a reversible MAO-A inhibitor--results of the drug utilization observation studies. | 1999 Mar |
1 |
| 45 |
10334000 | Moclobemide treatment in multiple sclerosis patients with comorbid depression: an open-label safety trial. | 1999 Spring |
1 |
| 46 |
10410765 | Moclobemide in patients with dementia and depression. | 1999 |
1 |
| 47 |
10417495 | The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers. | 1999 Aug |
2 |
| 48 |
9534836 | Placebo-controlled trial of moclobemide in social phobia. | 1998 Jan |
1 |
| 49 |
9579294 | The therapeutic effect of moclobemide, a reversible selective monoamine oxidase A inhibitor, in Parkinson's disease. | 1998 Mar-Apr |
2 |
| 50 |
9656095 | Medication treatments for panic disorder and social phobia. | 1998 |
1 |